ABCG2 and cancer: This discrepancy might be explained by a significant increase in expression of the ABC transporters at this particular time-point (shown in Figure 6), thereby suggesting a decreased intensity of DNA damage in cancer cells due to the effective efflux of the chemotherapeutic agent from cancer cells.